Interleukin-18 (Alkermes)

N/A

Report date: 2023/10/07 17:01:08
NME

Base Information

Drug NameInterleukin-18 (Alkermes)
Drug Alias NameIL-18 (Alkermes)IL-18
ClassificationOther
Mechanisms of ActionInterleukin-18 replacements
TargetsInterleukin 18
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIreland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlkermes Plc
China Registration ClassN/A

Develop Information

Active CompaniesAlkermes Plc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A